Gilles Hittinger

2.3k total citations
19 papers, 514 citations indexed

About

Gilles Hittinger is a scholar working on Virology, Infectious Diseases and Oncology. According to data from OpenAlex, Gilles Hittinger has authored 19 papers receiving a total of 514 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Virology, 17 papers in Infectious Diseases and 4 papers in Oncology. Recurrent topics in Gilles Hittinger's work include HIV Research and Treatment (18 papers), HIV/AIDS drug development and treatment (15 papers) and HIV/AIDS Research and Interventions (12 papers). Gilles Hittinger is often cited by papers focused on HIV Research and Treatment (18 papers), HIV/AIDS drug development and treatment (15 papers) and HIV/AIDS Research and Interventions (12 papers). Gilles Hittinger collaborates with scholars based in France, United States and Germany. Gilles Hittinger's co-authors include Alain Lafeuillade, Cécile Poggi, Philippe Halfon, Caroline Solas, Bruno Lacarelle, N. Profizi, D Émilie, E. Counillon, Hacène Khiri and S. Chadapaud and has published in prestigious journals such as The Journal of Infectious Diseases, Antimicrobial Agents and Chemotherapy and AIDS.

In The Last Decade

Gilles Hittinger

19 papers receiving 497 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gilles Hittinger France 12 465 398 108 83 78 19 514
Richard Loftus United States 6 460 1.0× 434 1.1× 76 0.7× 124 1.5× 93 1.2× 12 600
Radjin Steingrover Netherlands 11 418 0.9× 381 1.0× 135 1.3× 91 1.1× 89 1.1× 15 530
Rieneke M. E. van Praag Netherlands 12 531 1.1× 419 1.1× 69 0.6× 160 1.9× 209 2.7× 12 694
Joon Chang Australia 11 297 0.6× 188 0.5× 72 0.7× 139 1.7× 77 1.0× 14 400
Laura P. Kincer United States 8 317 0.7× 246 0.6× 77 0.7× 67 0.8× 105 1.3× 15 406
Audrey Taïeb France 11 217 0.5× 230 0.6× 43 0.4× 44 0.5× 56 0.7× 22 337
Zacarias da Silva Guinea-Bissau 12 325 0.7× 255 0.6× 45 0.4× 212 2.6× 114 1.5× 17 507
Michela Violin Italy 16 713 1.5× 655 1.6× 49 0.5× 113 1.4× 130 1.7× 28 779
Marie Fuerst United States 7 278 0.6× 145 0.4× 60 0.6× 193 2.3× 93 1.2× 11 384
Piera Pierotti Italy 10 272 0.6× 226 0.6× 29 0.3× 104 1.3× 74 0.9× 21 402

Countries citing papers authored by Gilles Hittinger

Since Specialization
Citations

This map shows the geographic impact of Gilles Hittinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gilles Hittinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gilles Hittinger more than expected).

Fields of papers citing papers by Gilles Hittinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gilles Hittinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gilles Hittinger. The network helps show where Gilles Hittinger may publish in the future.

Co-authorship network of co-authors of Gilles Hittinger

This figure shows the co-authorship network connecting the top 25 collaborators of Gilles Hittinger. A scholar is included among the top collaborators of Gilles Hittinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gilles Hittinger. Gilles Hittinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Hittinger, Gilles, et al.. (2010). Drug interactions in the elderly HIV‐infected patient. Journal of the International AIDS Society. 13(S4). 1 indexed citations
2.
Lafeuillade, Alain, Antoine Chéret, Gilles Hittinger, & Cécile Poggi. (2009). HIV-1 Meningoencephalitis in Patients on Effective HAART. HIV Clinical Trials. 10(3). 200–202. 2 indexed citations
3.
Lafeuillade, Alain, Antoine Chéret, Gilles Hittinger, et al.. (2009). Rectal Cell-Associated HIV-1 RNA: A New Marker Ready for the Clinic. HIV Clinical Trials. 10(5). 324–327. 11 indexed citations
4.
Lafeuillade, Alain, et al.. (2004). Highlights from the 13th International Symposium on HIV and Emerging Infectious Diseases (ISHEID). HIV Clinical Trials. 5(5). 305–322. 1 indexed citations
5.
Lafeuillade, Alain, Cécile Poggi, Gilles Hittinger, E. Counillon, & D Émilie. (2003). Predictors of Plasma Human Immunodeficiency Virus Type 1 RNA Control after Discontinuation of Highly Active Antiretroviral Therapy Initiated at Acute Infection Combined with Structured Treatment Interruptions and Immune‐Based Therapies. The Journal of Infectious Diseases. 188(10). 1426–1432. 42 indexed citations
6.
Lafeuillade, Alain, et al.. (2002). Differences in the detection of three HIV-1 protease inhibitors in non-blood compartments: Clinical correlations. HIV Clinical Trials. 3(1). 27–35. 64 indexed citations
7.
Solas, Caroline, et al.. (2002). Discrepancies between Protease Inhibitor Concentrations and Viral Load in Reservoirs and Sanctuary Sites in Human Immunodeficiency Virus-Infected Patients. Antimicrobial Agents and Chemotherapy. 47(1). 238–243. 145 indexed citations
8.
Lafeuillade, Alain, et al.. (2001). HIV-1 Induction-Maintenance at the Lymph Node Level: The “Apollo-97” Study. JAIDS Journal of Acquired Immune Deficiency Syndromes. 28(2). 154–157. 1 indexed citations
9.
Lafeuillade, Alain, et al.. (2001). Pilot Study of a Combination of Highly Active Antiretroviral Therapy and Cytokines to Induce HIV-1 Remission. JAIDS Journal of Acquired Immune Deficiency Syndromes. 26(1). 44–55. 44 indexed citations
10.
Lafeuillade, Alain, Cécile Poggi, Gilles Hittinger, & S. Chadapaud. (2001). Phenotypic and genotypic resistance to nucleoside reverse transcriptase inhibitors in HIV‐1 clinical isolates. HIV Medicine. 2(4). 231–235. 11 indexed citations
11.
Lafeuillade, Alain, et al.. (2001). Persistence of HIV-1 resistance in lymph node mononuclear cell RNA despite effective HAART. AIDS. 15(15). 1965–1969. 22 indexed citations
12.
Lafeuillade, Alain, et al.. (2001). Impact of immune interventions on proviral HIV‐1 DNA decay in patients receiving highly active antiretroviral therapy. HIV Medicine. 2(3). 189–194. 21 indexed citations
13.
Lafeuillade, Alain, et al.. (2001). HIV-1 Induction-Maintenance at the Lymph Node Level: The “Apollo-97” Study. JAIDS Journal of Acquired Immune Deficiency Syndromes. 28(2). 154–157. 1 indexed citations
14.
Lafeuillade, Alain, et al.. (2001). Pilot Study of a Combination of Highly Active Antiretroviral Therapy and Cytokines to Induce HIV-1 Remission. JAIDS Journal of Acquired Immune Deficiency Syndromes. 26(1). 44–55. 12 indexed citations
15.
Lafeuillade, Alain, et al.. (2001). Potential Adverse Effects of Structured Therapeutic Interruptions on the Pool of HIV-Infected Cells. JAIDS Journal of Acquired Immune Deficiency Syndromes. 28(2). 197–199. 1 indexed citations
16.
Poggi, Cécile, et al.. (1999). Long-term evaluation of triple nucleoside therapy administered from primary HIV-1 infection. AIDS. 13(10). 1213–1220. 23 indexed citations
17.
Hittinger, Gilles, et al.. (1998). Correlation between plasma levels of cytokines and HIV-1 RNA copy number in HIV-infected patients. Infection. 26(2). 100–103. 33 indexed citations
18.
Lafeuillade, Alain, et al.. (1998). Residual Human Immunodeficiency Virus Type 1 RNA in Lymphoid Tissue of Patients with Sustained Plasma RNA of <200 Copies/mL. The Journal of Infectious Diseases. 177(1). 235–238. 59 indexed citations
19.
Lafeuillade, Alain, et al.. (1997). Lymph Node Expansion of CD4+Lymphocytes during Antiretroviral Therapy. The Journal of Infectious Diseases. 176(5). 1378–1382. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Richard Loftus Breakdown of academic impact, for papers by Radjin Steingrover Breakdown of academic impact, for papers by Rieneke M. E. van Praag Breakdown of academic impact, for papers by Joon Chang Breakdown of academic impact, for papers by Laura P. Kincer Breakdown of academic impact, for papers by Audrey Taïeb Breakdown of academic impact, for papers by Zacarias da Silva Breakdown of academic impact, for papers by Michela Violin Breakdown of academic impact, for papers by Marie Fuerst Breakdown of academic impact, for papers by Piera Pierotti
Rankless by CCL
2026